Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Long-Term Outcomes in Patients Undergoing Thoracic Endovascular Aortic Repair. Single Center Experience

Version 1 : Received: 14 August 2023 / Approved: 15 August 2023 / Online: 16 August 2023 (09:17:03 CEST)

How to cite: Dokollari, A.; Sicouri, S.; Torregrossa, G.; Rodriguez, R.; Meisner, R.; Hirsch, H.; DiGiovanni, V.; Uribe, A.; Bacchi, B.; Cabrucci, F.; Chiarello, B.; Ramlawi, B.; Bonacchi, M. Long-Term Outcomes in Patients Undergoing Thoracic Endovascular Aortic Repair. Single Center Experience. Preprints 2023, 2023081197. https://doi.org/10.20944/preprints202308.1197.v1 Dokollari, A.; Sicouri, S.; Torregrossa, G.; Rodriguez, R.; Meisner, R.; Hirsch, H.; DiGiovanni, V.; Uribe, A.; Bacchi, B.; Cabrucci, F.; Chiarello, B.; Ramlawi, B.; Bonacchi, M. Long-Term Outcomes in Patients Undergoing Thoracic Endovascular Aortic Repair. Single Center Experience. Preprints 2023, 2023081197. https://doi.org/10.20944/preprints202308.1197.v1

Abstract

Background: To analyze long-term outcomes in patients undergoing thoracic endovascular aortic repair (TEVAR). Methods: All consecutive 97 patients undergoing TEVAR between September 2014 and September 2022 were included in the study. Primary outcome was long-term incidence of overall death and major adverse cardiovascular and cerebrovascular events (MACCE). Results: Mean age was 70.4 years, and 22(23.2%) had cerebrovascular disease (CBVD). A total of 49(51.6%) of patients had prior cardiac surgery intervention and 8(8.5%) had prior aortic valve replacement. Twenty-eight patients(28.8%) presented with aortic dissection, 60(61.8%) had aortic aneurysm, 4(4.1%) had intramural hematoma, and 5(5.1%) had other presentations. An emergent procedure was performed in 6(6.2%) patients, an urgent procedure in 37(38.1%) patients and 54(55.7%) patients had an elective procedure. Intraoperatively, 78.3% had percutaneous TEVAR, 5.1% had ministernotomy TEVAR, while 10.3% had concomitant full sternotomy TEVAR repair. Hospital mortality was 7 patients(7.2%). At 8-years follow-up, 76% were alive, 25.8% had MACCE, 21.6% were diagnosed with endoleaks(13 patients type II and 2 patients type 1) while 10.3% un-derwent repeat intervention. Conclusions: This single center experience in patients undergoing TEVAR evidenced good short and long-term survival and MACCE. Nonetheless, almost half of the patients underwent an ur-gent/emergent procedure, clinical results were favourable for TEVAR.

Keywords

TEVAR; long-term outcome; MACCE

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.